DBV Technologies Reports Full Year 2025 Financial Results and Business Update
DBV Technologies reported full-year 2025 financial results highlighting advances in its VIASKIN Peanut Patch clinical development for peanut-allergic children and toddlers. The company strengthened its leadership in preparation for the Biologics License Application (BLA) submission for U.S. approval and secured significant financing to fund operati…